Skip to main content
CHEMCLIN DIAGNOSTICS CO., LTD. logo

CHEMCLIN DIAGNOSTICS CO., LTD. — Investor Relations & Filings

Ticker · 688468 ISIN · CNE100005311 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 511 across all filing types
Latest filing 2025-08-20 Governance Information
Country CN China
Listing Shanghai Stock Exchange 688468

About CHEMCLIN DIAGNOSTICS CO., LTD.

https://www.chemclin.com/

CHEMCLIN DIAGNOSTICS CO., LTD. specializes in the research, development, and manufacturing of in vitro diagnostic systems and reagents. The company is primarily recognized for its proprietary Light-initiated Chemiluminescent Assay (LiCA) technology, a homogeneous chemiluminescence platform that eliminates the need for washing steps, thereby enhancing testing efficiency and precision. Its product portfolio includes fully automated immunoassay analyzers and a comprehensive range of diagnostic kits covering infectious diseases, cardiac markers, thyroid function, tumor markers, and reproductive health. By integrating advanced biotechnology with automated instrumentation, the company provides clinical laboratories and medical institutions with high-sensitivity diagnostic solutions designed to improve patient care and laboratory workflow.

Recent filings

Filing Released Lang Actions
科美诊断技术股份有限公司信息披露管理制度（2025年8月）
Governance Information Classification · 95% confidence The document is a detailed information disclosure management system of a company, outlining the rules and standards for information disclosure, including definitions, types of reports (annual, semi-annual, quarterly), timing, content requirements, and procedures for disclosure of major events, transactions, risks, and other significant matters. It references regulatory bodies such as the China Securities Regulatory Commission and Shanghai Stock Exchange, and covers comprehensive disclosure obligations and standards. The document is not an actual report (like an annual report or interim report) but rather a governance or procedural document detailing how the company manages and discloses information. It does not contain financial statements or results but sets the framework for disclosures. Therefore, it fits best under Governance Information (CGR), which covers reports detailing the company's internal rules, board structure, and governance practices.
2025-08-20 Chinese
科美诊断技术股份有限公司关联交易管理办法（2025年8月）
Governance Information Classification · 95% confidence The document is titled as a management policy document regarding related party transactions (关联交易管理办法) for 科美诊断技术股份有限公司. It details the principles, scope, disclosure, pricing, and approval procedures for related party transactions. It is a governance and compliance document outlining internal rules and procedures rather than a financial report, announcement, or regulatory filing. There is no indication of financial statements, audit results, earnings data, or meeting materials. It is not a report publication announcement or a certification. The content fits best under Governance Information (CGR) as it details governance practices related to related party transactions.
2025-08-20 Chinese
科美诊断技术股份有限公司对外投资管理办法（2025年8月）
Governance Information Classification · 95% confidence The document is titled '科美诊断技术股份有限公司对外投资管理办法' which translates to 'Kemei Diagnostic Technology Co., Ltd. External Investment Management Measures'. It is a detailed internal policy document outlining the principles, approval authorities, organizational structure, decision-making, personnel management, financial management, and auditing related to the company's external investments. There is no indication that this is a financial report, earnings release, or regulatory filing. It is not an announcement or a report publication notice. It is a governance-related document describing internal rules and procedures for managing external investments. Therefore, it fits best under Governance Information (CGR). The document length is 4369 characters, which is sufficient for a substantive policy document. No financial statements or audit reports are included, so it is not an Annual Report or Audit Report. No mention of board changes or voting results, so not MANG or DVA. No conference call transcript or investor presentation. Hence, the classification is CGR with high confidence.
2025-08-20 Chinese
科美诊断技术股份有限公司独立董事提名人声明与承诺（宣建伟）
Board/Management Information Classification · 95% confidence The document is a formal statement nominating an independent director candidate for the company's board. It details the qualifications, independence criteria, and compliance with relevant laws and regulations for the nominee. There is no financial data, no report or results announcement, no mention of voting results, no legal proceedings, no capital changes, and no earnings information. The content is focused on board/management information, specifically the nomination of a board member. The document length is short (1817 characters), but it is not an announcement of a report publication or a certification letter; it is a substantive declaration related to board management. Therefore, the appropriate classification is Board/Management Information (MANG).
2025-08-20 Chinese
科美诊断技术股份有限公司章程（2025年8月）
Governance Information Classification · 100% confidence The document is titled as the Articles of Association (章程) of 科美诊断技术股份有限公司, dated August 2025. It contains detailed company governance rules, shareholder rights, board structure, share issuance and transfer rules, financial accounting systems, audit provisions, and other corporate governance matters. It references relevant laws and regulations such as the Company Law, Securities Law, and Shanghai Stock Exchange listing rules. The content is a comprehensive governance document outlining the internal rules and structure of the company rather than a financial report or announcement. It is not an annual report, interim report, earnings release, or any other financial statement. It is not a proxy statement or voting results announcement. It is not a regulatory filing or legal proceeding update. The document fits the definition of Governance Information (CGR), which details the company's internal rules, board structure, and governance practices.
2025-08-20 Chinese
科美诊断技术股份有限公司关于修订《公司章程》及公司部分治理制度的公告
Governance Information Classification · 95% confidence The document is a detailed announcement from the board of directors of 科美诊断技术股份有限公司 regarding amendments to the company's Articles of Association and various governance rules. It references compliance with Shanghai Stock Exchange rules and Chinese securities laws, and discusses governance structures, board responsibilities, and shareholder meeting procedures. The document is not a financial report, earnings release, or audit report, nor is it a transcript or capital update. It focuses on governance and internal company rules, including board and shareholder meeting rules, related to corporate governance. Therefore, it fits best under the category of Governance Information (CGR). The document length and detail confirm it is the actual governance document, not just an announcement of publication.
2025-08-20 Chinese

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.